Literature DB >> 4362523

Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.

I Yron, D W Weiss, E Robinson, D Cohen, M G Adelberg, T Mekori, M Haber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4362523

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  4 in total

1.  Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG).

Authors:  E Robinson; A Bartal; Y Cohen; N Haim; J Mohilever; T Mekori
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Effect of treatment with the MER tubercle bacilli fraction on the survival of mice carrying mammary tumour isografts: injections of MER at the tumour site or at a distal location.

Authors:  D Cohen; L Yron; M Haber; E Robinson; D W Weiss
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

3.  A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.

Authors:  E Robinson; A Bartal; Y Cohen; R Haasz
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

4.  CpG plus radiotherapy: a review of preclinical works leading to clinical trial.

Authors:  Kathy A Mason; Nancy R Hunter
Journal:  Front Oncol       Date:  2012-08-14       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.